Literature DB >> 3016851

Serial inoculation of sheep with two bluetongue virus types.

M H Jeggo, R C Wardley, J Brownlie, A H Corteyn.   

Abstract

Groups of sheep inoculated with bluetongue virus type 4 were challenged at various intervals after inoculation (from seven to 70 days) with bluetongue virus type 3. Examination of the clinical and serological response showed that animals were protected from challenge with a second bluetongue virus for up to 14 days after the inoculation of the first virus type. An adoptive transfer experiment in monozygotic sheep involving both antibody and T lymphocytes was carried out. Only partial protection was observed against heterologous virus challenge, indicating that although the T cell response has a cross-protective component, antibody is not involved. These observations indicate that current vaccination procedures should be reappraised, particularly in terms of revaccination with multiple bluetongue virus type.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016851

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  9 in total

1.  Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains.

Authors:  Sushila Maan; Narender S Maan; Piet A van Rijn; René G P van Gennip; Anna Sanders; Isabel M Wright; Carrie Batten; Bernd Hoffmann; Michael Eschbaumer; Chris A L Oura; Abraham C Potgieter; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

2.  RT-PCR assays for seven serotypes of epizootic haemorrhagic disease virus & their use to type strains from the Mediterranean region and North America.

Authors:  Narender S Maan; Sushila Maan; Kyriaki Nomikou; Donna J Johnson; Mehdi El Harrak; Hafsa Madani; Hagai Yadin; Serife Incoglu; Kadir Yesilbag; Andrew B Allison; David E Stallknecht; Carrie Batten; Simon J Anthony; Peter P C Mertens
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

3.  Characterization of the immune response induced by a commercially available inactivated bluetongue virus serotype 1 vaccine in sheep.

Authors:  Ana Cristina Pérez de Diego; Pedro José Sánchez-Cordón; Ana Isabel de las Heras; José Manuel Sánchez-Vizcaíno
Journal:  ScientificWorldJournal       Date:  2012-04-24

4.  Serotype specific primers and gel-based RT-PCR assays for 'typing' African horse sickness virus: identification of strains from Africa.

Authors:  Narender S Maan; Sushila Maan; Kyriaki Nomikou; Manjunatha N Belaganahalli; Katarzyna Bachanek-Bankowska; Peter P C Mertens
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

5.  Identification and differentiation of the twenty six bluetongue virus serotypes by RT-PCR amplification of the serotype-specific genome segment 2.

Authors:  Narender S Maan; Sushila Maan; Manjunatha N Belaganahalli; Eileen N Ostlund; Donna J Johnson; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

6.  Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.

Authors:  Cristina C Celma; Meredith Stewart; Kerstin Wernike; Michael Eschbaumer; Lorenzo Gonzalez-Molleda; Emmanuel Breard; Claudia Schulz; Bernd Hoffmann; Andy Haegeman; Kris De Clercq; Stephan Zientara; Piet A van Rijn; Martin Beer; Polly Roy
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

Review 7.  The Interplay between Bluetongue Virus Infections and Adaptive Immunity.

Authors:  Daniel Rodríguez-Martín; Andrés Louloudes-Lázaro; Miguel Avia; Verónica Martín; José M Rojas; Noemí Sevilla
Journal:  Viruses       Date:  2021-07-31       Impact factor: 5.048

8.  Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR -/- mice.

Authors:  Petra C Fay; Houssam Attoui; Carrie Batten; Fauziah Mohd Jaafar; George P Lomonossoff; Janet M Daly; Peter P C Mertens
Journal:  Vaccine X       Date:  2019-06-22

Review 9.  A review of experimental infections with bluetongue virus in the mammalian host.

Authors:  Peter Coetzee; Moritz van Vuuren; Estelle H Venter; Maria Stokstad
Journal:  Virus Res       Date:  2014-01-24       Impact factor: 3.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.